Stem Cells are indistinguishable cells which are capable of Making Non-regenerative cells, such as brain and myocardial cells
Stem cells are the body's raw materials — they are the cells
that give rise to all other cells with specialised tasks. Stem cells divide to
generate new cells called daughter cells under the correct conditions in the
body or in the lab. These daughter cells either self-renew or differentiate
into specialised cells with a more specific role, such as blood cells, brain
cells, heart muscle cells, or bone cells (differentiation). No other cell in
the body has the potential to produce new cell types on its own.
Stem cells are unique human cells that can differentiate
into a variety of cell types. From muscle cells to brain cells, this can
happen. They can also repair damaged tissues in some circumstances. Stem
cell-based therapies, according to researchers, could one day be utilised to
cure major disorders including paralysis and Alzheimer's disease. The global Stem
Cells Market is estimated to account for US$ 9,941.2 Mn in terms of
value in 2020 and is expected to reach US$ 18,289.9 Mn by the end of 2027.
Over the forecast period, the global stem cells market is
expected to develop due to the approval and launch of new products. For
example, the Israeli Patent Office granted BioRestorative Therapies, Inc. a
Notice of Allowance on their patent application for a technique of manufacturing
brown fat stem cells in December 2019. Furthermore, the industry is predicted
to rise as the number of stem cell banking resource centres grows. For example,
in March 2020, Stemlife Berhad, a Malaysian cord blood bank, opened a Stem Cell
Banking Resource Center in Brunei's Jerudong Park Medical Center.
The high cost of stem cell therapy is projected to stifle
the global stem
cell market growth. According to Bioinformant, a stem cell research
firm, the cost of stem cell therapy varies between US$ 5,000 and US$ 8,000 each
patient, with some cases costing as much as US$ 25,000 or more depending on the
procedure's intricacy. Furthermore, limits on stem cell research have
historically restricted embryonic stem cell growth, resulting in a small share
of the overall market despite its benefits over adult stem cells.
For companies in the global stem cell market, R&D in
stem cell donation is likely to provide lucrative growth prospects. Researchers
from Dankook University and Catholic University in South Korea, for example,
published a study in March 2020 that looked into the types and degrees of
physical and psychological discomfort experienced by hematopoietic stem cell
donors before, during, and after the donation process. Furthermore, the global
stem cell market is likely to benefit from the implementation of online
distribution channels. According to "The US Direct-to-Consumer Marketplace
for Autologous Stem Cell Interventions," published in the journal
Perspectives in Biology and Medicine in 2018, between 2009 and 2014, the number
of new stem cell enterprises with websites in the United States doubled on
average every year.
Comments
Post a Comment